Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The study is to evaluate the accuracy and safety of a novel real-time CGM system among adult patients with type 1 diabetes mellitus with respect to YSI reference venous plasma sample measurements.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥ 18 years

• Diagonsed with T1DM or T2DM

• Venous blood sampling access can be established in the forearm

• Capable of independently reading instructions and complying with the clinical trial requirements

• Willing to sign the Informed Consent Form (ICF)

Locations
Other Locations
China
Henan University of Science and Technology
RECRUITING
Luoyang
Contact Information
Primary
Peng Liu
peng.liu87@outlook.com
0379-64811993
Time Frame
Start Date: 2025-04-01
Estimated Completion Date: 2026-09-01
Participants
Target number of participants: 36
Treatments
Other: Adult patients with T1DM or T2DM
Related Therapeutic Areas
Sponsors
Leads: Henan University of Science and Technology

This content was sourced from clinicaltrials.gov